2013
DOI: 10.1007/s00535-013-0806-1
|View full text |Cite
|
Sign up to set email alerts
|

Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis

Abstract: This meta-analysis showed that PS placement prevented PEP after ERCP as compared with no PS placement. We therefore recommend PS placement after ERCP for the prevention of PEP.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
131
4
4

Year Published

2014
2014
2022
2022

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 196 publications
(143 citation statements)
references
References 41 publications
4
131
4
4
Order By: Relevance
“…This found that pancreatic stent placement was associated with significant reduction of post-ERCP pancreatitis (RR=0.39, 95%CI: 0.29-0.53, P < 0.001) as compared with no stent placement. Subgroup analysis demonstrated that pancreatic stent placement was effective for both high-risk and mixed case groups [34] . Another meta-analysis by Choudhary et al [35] analysed eight RCTs (656 patients) and this showed that prophylactic pancreatic stents decreased the odds of post-ERCP pancreatitis (OR = 0.22; 95%CI: 0.12-0.38, P < 0.01) with an absolute risk difference of 13%.…”
Section: Ercp Techniquementioning
confidence: 99%
“…This found that pancreatic stent placement was associated with significant reduction of post-ERCP pancreatitis (RR=0.39, 95%CI: 0.29-0.53, P < 0.001) as compared with no stent placement. Subgroup analysis demonstrated that pancreatic stent placement was effective for both high-risk and mixed case groups [34] . Another meta-analysis by Choudhary et al [35] analysed eight RCTs (656 patients) and this showed that prophylactic pancreatic stents decreased the odds of post-ERCP pancreatitis (OR = 0.22; 95%CI: 0.12-0.38, P < 0.01) with an absolute risk difference of 13%.…”
Section: Ercp Techniquementioning
confidence: 99%
“…In the latest meta-analysis including 14 studies, pancreatic duct stent placement was associated with a statistically significant reduction of PEP (RR 0.39; 95 % CI 0.29-0.53; p < 0.001). Subgroup analysis stratified according to the severity of PEP showed that a stent was beneficial in patients with mild to moderate PEP (RR 0.45; 95 % CI 0.32-0.62; p < 0.001) and in patients with severe PEP (RR 0.26; 95 %CI 0.09-0.76; p = 0.01) [23][24][25].…”
Section: Guidewire Cannulationmentioning
confidence: 95%
“…In a meta-analysis by Mazaki et al, PSP was shown to reduce rates of post-ERCP pancreatitis from 19% in the control group to 7% in the stent group. 3 In one account, failed PSP in patients saw PEP in 35% of cases, compared to 13-29% in those where PSP was not attempted. At present, there are eight randomized controlled studies and two meta-analyses addressing this topic.…”
Section: Literature Reviewmentioning
confidence: 99%